Efficacy of 12 weeks oral beta-alanine supplementation in patients with chronic obstructive pulmonary disease: a double-blind, randomized, placebo-controlled trial.
Carnosine
Chronic obstructive pulmonary disease
Oxidative/carbonyl stress
Physical capacity
Journal
Journal of cachexia, sarcopenia and muscle
ISSN: 2190-6009
Titre abrégé: J Cachexia Sarcopenia Muscle
Pays: Germany
ID NLM: 101552883
Informations de publication
Date de publication:
10 2022
10 2022
Historique:
revised:
28
04
2022
received:
03
12
2021
accepted:
14
06
2022
pubmed:
18
8
2022
medline:
6
10
2022
entrez:
17
8
2022
Statut:
ppublish
Résumé
Beta-alanine (BA) supplementation increases muscle carnosine, an abundant endogenous antioxidant and pH buffer in skeletal muscle. Carnosine loading promotes exercise capacity in healthy older adults. As patients with chronic obstructive pulmonary disease (COPD) suffer from elevated exercise-induced muscle oxidative/carbonyl stress and acidosis, and from reduced muscle carnosine stores, it was investigated whether BA supplementation augments muscle carnosine and induces beneficial changes in exercise capacity, quadriceps function, and muscle oxidative/carbonyl stress in patients with COPD. In this double-blind, randomized, placebo (PL)-controlled trial (clinicaltrials.gov identifier: NCT02770417), 40 patients (75% male) with COPD (mean ± standard deviation: age 65 ± 6 years; FEV Beta-alanine supplementation increased muscle carnosine in comparison with PL in patients with COPD (mean difference [95% confidence interval]; +2.82 [1.49-4.14] mmol/kg wet weight; P < 0.001). Maximal incremental cycling capacity (VO Beta-alanine supplementation is efficacious in augmenting muscle carnosine (+54% from mean baseline value) without side effects in patients with COPD in comparison with PL. However, accompanied beneficial changes in exercise capacity, quadriceps function, and muscle oxidative/carbonyl stress were not observed.
Sections du résumé
BACKGROUND
Beta-alanine (BA) supplementation increases muscle carnosine, an abundant endogenous antioxidant and pH buffer in skeletal muscle. Carnosine loading promotes exercise capacity in healthy older adults. As patients with chronic obstructive pulmonary disease (COPD) suffer from elevated exercise-induced muscle oxidative/carbonyl stress and acidosis, and from reduced muscle carnosine stores, it was investigated whether BA supplementation augments muscle carnosine and induces beneficial changes in exercise capacity, quadriceps function, and muscle oxidative/carbonyl stress in patients with COPD.
METHODS
In this double-blind, randomized, placebo (PL)-controlled trial (clinicaltrials.gov identifier: NCT02770417), 40 patients (75% male) with COPD (mean ± standard deviation: age 65 ± 6 years; FEV
RESULTS
Beta-alanine supplementation increased muscle carnosine in comparison with PL in patients with COPD (mean difference [95% confidence interval]; +2.82 [1.49-4.14] mmol/kg wet weight; P < 0.001). Maximal incremental cycling capacity (VO
CONCLUSIONS
Beta-alanine supplementation is efficacious in augmenting muscle carnosine (+54% from mean baseline value) without side effects in patients with COPD in comparison with PL. However, accompanied beneficial changes in exercise capacity, quadriceps function, and muscle oxidative/carbonyl stress were not observed.
Identifiants
pubmed: 35977911
doi: 10.1002/jcsm.13048
pmc: PMC9530565
doi:
Substances chimiques
Antioxidants
0
beta-Alanine
11P2JDE17B
Carnosine
8HO6PVN24W
Banques de données
ClinicalTrials.gov
['NCT02770417']
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2361-2372Subventions
Organisme : São Paulo Research Foundation (FAPESP)
ID : 2019/10744-3
Organisme : Limburgs Kankerfonds
Organisme : FWO
ID : 11B4718N
Informations de copyright
© 2022 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders.
Références
J Cachexia Sarcopenia Muscle. 2021 Dec;12(6):2259-2261
pubmed: 34904399
Front Physiol. 2020 Aug 14;11:913
pubmed: 32922303
Eur J Clin Nutr. 2020 Aug;74(8):1181-1191
pubmed: 32123345
Eur J Appl Physiol. 2010 Feb;108(3):495-503
pubmed: 19841932
Am J Physiol Regul Integr Comp Physiol. 2021 Jun 1;320(6):R824-R832
pubmed: 33789445
Amino Acids. 2012 Jun;42(6):2461-72
pubmed: 21847611
Amino Acids. 2012 Jul;43(1):49-56
pubmed: 22143432
Front Nutr. 2015 May 07;2:13
pubmed: 25988141
Amino Acids. 2006 May;30(3):279-89
pubmed: 16554972
J Int Soc Sports Nutr. 2008 Nov 07;5:21
pubmed: 18992136
J Appl Physiol (1985). 2013 May;114(9):1319-28
pubmed: 22815389
Adv Nutr. 2019 May 1;10(3):452-463
pubmed: 30980076
Am J Respir Crit Care Med. 2018 Jul 15;198(2):175-186
pubmed: 29554438
Br J Sports Med. 2017 Apr;51(8):658-669
pubmed: 27797728
J Cachexia Sarcopenia Muscle. 2022 Oct;13(5):2361-2372
pubmed: 35977911
Med Sci Sports Exerc. 2017 Mar;49(3):602-609
pubmed: 28106620
J Int Soc Sports Nutr. 2018 Jul 11;15(1):32
pubmed: 29996843
J Appl Physiol (1985). 2021 Oct 1;131(4):1230-1240
pubmed: 34323590
Br J Nutr. 2018 Apr;119(7):759-770
pubmed: 29569535
Amino Acids. 2012 Jul;43(1):67-76
pubmed: 22139410
Eur Respir J. 2006 Jun;27(6):1110-8
pubmed: 16540501
Clin Chest Med. 2014 Mar;35(1):51-69
pubmed: 24507837
J Am Med Dir Assoc. 2012 Mar;13(3):291-7
pubmed: 21778120
Am J Respir Crit Care Med. 1996 Jan;153(1):288-93
pubmed: 8542131
Am J Respir Crit Care Med. 2014 May 1;189(9):e15-62
pubmed: 24787074
Eur J Appl Physiol Occup Physiol. 1992;64(1):47-50
pubmed: 1735411
J Inflamm Res. 2021 Sep 07;14:4503-4507
pubmed: 34522118
Exp Gerontol. 2013 Sep;48(9):933-9
pubmed: 23832078
Front Nutr. 2019 Aug 27;6:135
pubmed: 31508423
J Appl Physiol (1985). 2014 Jan 15;116(2):204-9
pubmed: 24285150
Amino Acids. 2012 Jul;43(1):25-37
pubmed: 22270875
Eur Respir J. 2010 Jul;36(1):81-8
pubmed: 19897554
Physiol Rev. 2013 Oct;93(4):1803-45
pubmed: 24137022
Redox Biol. 2018 Sep;18:222-228
pubmed: 30053728
Biofactors. 2005;24(1-4):77-87
pubmed: 16403966
J Int Soc Sports Nutr. 2015 Jul 15;12:30
pubmed: 26175657
Amino Acids. 2018 Sep;50(9):1177-1186
pubmed: 29858687
J Appl Physiol (1985). 2018 Oct 18;:
pubmed: 30335580
Mol Cell Biochem. 2001 Sep;225(1-):29-34
pubmed: 11716361
J Physiol. 2016 Sep 1;594(17):4849-63
pubmed: 27062388
Int J Chron Obstruct Pulmon Dis. 2014 Jun 05;9:589-95
pubmed: 24940055
BMJ Open. 2020 Sep 13;10(9):e038836
pubmed: 32928863